Descriptor English: | Denosumab | ||||
Descriptor Spanish: |
Denosumab
| ||||
Descriptor Portuguese: | Denosumab | ||||
Descriptor French: | Dénosumab | ||||
Entry term(s): |
AMG 162 Prolia Xgeva |
||||
Tree number(s): |
D12.776.124.486.485.114.224.060.782 D12.776.124.790.651.114.224.060.782 D12.776.377.715.548.114.224.200.782 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069448 | ||||
Scope note: | A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||
Pharm Action: |
Bone Density Conservation Agents |
||||
Registry Number: | 4EQZ6YO2HI | ||||
Public MeSH Note: | 2016; DENOSUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2015; and under ANTIBODIES, MONOCLONAL 2004-2012 |
||||
History Note: | 2016 (2004) |
||||
Related: |
RANK Ligand
MeSH | ||||
DeCS ID: | 55976 | ||||
Unique ID: | D000069448 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2016/01/01 | ||||
Date of Entry: | 2015/07/01 | ||||
Revision Date: | 2017/06/20 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Denosumab
- Preferred
Xgeva
- Narrower
AMG 162
- Narrower
Prolia
- Narrower
Concept UI |
M0493770 |
Scope note | A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. |
Preferred term | Denosumab |
Concept UI |
M0554986 |
Preferred term | Xgeva |
Concept UI |
M0478464 |
Preferred term | AMG 162 |
Concept UI |
M0555596 |
Preferred term | Prolia |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey